Leveraging our patented MUAS® Cognitive Assessment, SOLO® Behavioral Assessment, and a dataset of 4M+ real-world pharma interactions ,we transform every learning moment—every practice session, every simulated dialogue—into measurable, traceable, and visualized performance metrics. This delivers clear evidence of training ROI and actionable talent insights that fuel data-driven business growth.

To date, we serve 50+ leading global and Chinese life sciences companies, with 50,000+ users worldwide. Our R&D centers are in Shanghai and San Francisco, supported by teams across Switzerland, Japan, and Canada. Since our founding in 2017, we’ve secured 2 patents in data security and AI algorithms, achieved ISO 27001 certification and China’s Level 3 Cybersecurity Compliance, completed national algorithm regulatory filings, and published 15+ peer-reviewed papers in SCI-indexed and international academic journals.

Looking ahead, we will continue to power our platform with AI—deepening the integration of behavioral science and cognitive modeling—to become the industry’s most trusted “Training Value Quantification Partner.” We empower every medical professional to achieve capability leaps—and turn human potential into predictable, sustainable, and scalable business outcomes.